A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Partnership for Economic Innovation Secures Funding for Wearable Technology Research

The Partnership for Economic Innovation (PEI), a passionate collective of business and community leaders dedicated to accelerating Arizona’s economic opportunities, announced that the Arizona Commerce Authority had awarded $1.6 million to support 8 new applied research projects through its WearTech Applied Research Center. State funding matches private and nonstate funds committed by the industry partners.

The applied research model accelerates product development and commercialization by combining private and public sector. PEI’s WearTech Applied Research Center focuses on de-risking investment in future-of-health and biomedical technology. The center shepherds these innovative products though the idea generation, project formation, validation, and commercialization phases.

“At the WearTech Applied Research Center, we’ve been able to partner with businesses and universities, bringing together remarkable talent who are working on innovative solutions to advance health and human performance,” said Kathleen Lee, Director of Applied Research Centers for the Partnership for Economic Innovation. “We thank the Arizona Legislature for setting aside these public funds for applied research and appreciate the Arizona Commerce Authority for awarding these funds to help us advance critical research projects and hope they will continue to make similar investments in the future.”

During the 2021 legislative session, the State Legislature appropriated $5 million to distribute to applied research centers and institutes across the state, including $2.5 million for wearable technology applied research. The Arizona Commerce Authority then awarded funds to selected applicants of its Applied Research Program, including $1.6 million to a new cohort of 8 projects housed under the WearTech Applied Research Center.

“The WearTech Applied Research Center’s new projects represent the kinds of new technologies that are helping establish Arizona as a leader in the wearable technology sector,” said Brad Jannenga, Founder and Executive Chairman at Chassi and Board Member of PEI and the WearTech Applied Research Center. “Technology leaders in our state should be looking to the WearTech Center as a model to accelerate innovation in our state.”

The WearTech Center has so far supported the development and the path to commercialization of wearable technology projects, including a drug-free anxiety treatment device and dynamic fall risk assessment tool. This additional funding will support eight new projects, more than doubling the number of applied research projects through the WearTech Center and achieving 360% growth in total research funding compared to 2019. New research projects will help those with walking disabilities, develop a fetal monitor to detect compromising issues, create a wearable phototherapy device for treatment for thrush, and more.

The WearTech Center’s 2022 cohort of eight projects partner with one of Arizona’s three public universities: Arizona State University, University of Arizona and Northern Arizona University. The projects are:

  • Biomotum’s Wearable Robotic Ankle Assist Device (RAAD), an on-demand mobility assistance device to aid at-home functional gait training for individuals with a walking disability
  • GoX Labs’ and AKE’s Quasi-Active Exoskeleton (PhenEx), a device aimed at reducing work-related injuries and improving wellness with springs that aid activities like squatting or lifting
  • TouchPoint Solutions’ Anti-Anxiety Device, an over-the-counter device that combines look-up table and AI algorithms with (BLAST™) technology to reduce stress and anxiety
  • Movement Interactive’s Hiji®Band, an integrated solution for measuring acute injury in individuals exposed to brain injury
  • KLS’s Fetal Monitor, uses biosensors and machine learning to detect emerging compromises to a baby’s health status for intervention
  • TF Health Company’s Personal Exposure Badge-like Device, a personal exposure device wore like a badge that monitors air pollutants and a Breath Fat Oxidation Sensor, a sensing device that detects acetone in the breath to monitor adherence to calories in/calories out diets and ketogenic diets
  • 8Chili’s Virtual Reality for Medical Training technology and headband, a virtual reality simulation of clinical studies for medical students
  • Desert Platform’s Thrush Treatment Device, a wearable phototherapy device for least invasive, most natural, and fully mobile treatment for thrush

More here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Noze states the grant will fund a groundbreaking clinical study aimed at detecting TB in high-burden countries, using the company's DiagNoze® — a handheld breathalyzer designed for the real-time detection and screening of various medical conditions, including infectious diseases such as TB.
Research teams led by a faculty member in Purdue University’s College of Engineering will use two grants from the National Eye Institute totaling $6.7 million to further develop specialized smart soft contact lenses that continuously monitor or treat chronic ocular diseases like glaucoma, corneal neovascularization and dry eye syndromes.
The series B funding round saw participation from venture capital firms Blume Ventures, Steadview Capital, Nexus Venture Partners, Alpha Wave and Zomato founder Deepinder Goyal. Ultrahuman will deploy the funds towards building further manufacturing capacity and deeper research in the health tracking space notes Ultrahuman.
Bone Health Technologies Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the company has raised a...
Howard Robin, President and Chief Executive Officer of Nektar Therapeutics: "We are pleased to bring on TCGX as a new high-quality, long-term investor in Nektar as we advance rezpegaldesleukin through our Phase 2b studies in atopic dermatitis and alopecia areata. We are on track to report topline data from these studies in the first half of 2025, which will represent significant inflection points for Nektar. Today's financing further bolsters our financial position and extends the company's cash runway well into the third quarter of 2026."

By using this website you agree to accept Medical Device News Magazine Privacy Policy